analysis of cancer biomarkers in blood.

The company is developing tests that span all stages of lung cancer from aid in diagnosis for patients with early-stage disease to treatment stratification and monitoring in late-stage lung cancer. The company's diagnostic technology combined with machine learning and image analysis results in workflow efficiencies and improvement in performance.

It was founded in 2008 and is headquartered in Thousand Oaks, California.